Clinical Trials
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8857
Alternating Cisplatin/VP-16 with Continuous CAV and Consolidation Chemoradiotherapy for Extensive Small Cell Lung Cancer with PCI for Complete Responders
Activated
10-15-1989
Closed
05-15-1991
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8926
Evaluation of Low Dose Continuous Infusion 5-Fluorouracil in Patients with Advanced and Recurrent Renal Cell Carcinoma
Activated
10-01-1989
Closed
02-15-1991
Closed
Phase
Accrual
4%
SWOG Clinical Trial Number
SWOG-8999
Evaluation of Radiation Treatment Following Surgical Resection of Solitary Brain Metastasis
Activated
08-15-1989
Closed
12-15-1990
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8905
Phase II/III Study of Fluorouracil (5-FU) and its Modulation in Advanced Colorectal Cancer
Activated
08-01-1989
Closed
01-01-1993
Closed
Phase
Accrual
60%
Published
SWOG Clinical Trial Number
SWOG-8912
Evaluation of Fazarabine in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck
Activated
07-15-1989
Closed
01-01-1991
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8897
Comparison of Adjuvant Chemotherapy With or Without Endocrine Therapy in High-Risk, Node Negative Breast Cancer Patients, and a Natural History Follow-up Study in Low-Risk Node Negative Patients (to initially low risk patients)
Research Committee(s)
Breast Cancer
Activated
07-15-1989
Closed
02-01-1993
Closed
Phase
Accrual
46%
Published
SWOG Clinical Trial Number
SWOG-8907
A Phase ll Trial of Combination Chemotherapy Plus Verapamil in Drug Refractory Intermediate Grade and Selected High Grade Non-Hodgkin's Lymphomas
Activated
07-01-1989
Closed
12-15-1991
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8925
Evaluations of Cisplatin + VP-16 Followed by Mitotane at Progression if No Prior Mitotane or Cisplatin + VP-16 Only if Prior Treatment with Mitotane in Advanced and Metastatic Adrenal Cortical Carcinoma
Research Committee(s)
Genitourinary Cancer
Activated
06-15-1989
Closed
12-01-1995
Closed
Phase
Accrual
50%
SWOG Clinical Trial Number
SWOG-8816
Study of 13-cis Retinoic Acid (Accutane) Plus rIFN-A (Roferon-A) in Mycosis Fungoides
Activated
05-15-1989
Closed
01-01-1993
Closed
Phase
Accrual
71%
Published
SWOG Clinical Trial Number
SWOG-8892 (INT-0099) (EST-2388) (RTOG-8817)
A Study of Radiotherapy With or Without Concurrent Cisplatin in Patients with Nasopharyngeal Cancer
Research Committee(s)
Head and Neck Cancer
Activated
05-15-1989
Closed
12-01-1995
Closed
Phase
Accrual
77%
Published
SWOG Clinical Trial Number
SWOG-8807
An Investigation of the Relationship Between an Integrated, System Education Approach and Breast Self Exam (BSE) Compliance
Research Committee(s)
Breast Cancer
Activated
05-15-1989
Closed
12-01-1993
Closed
Phase
Accrual
88%
Published
SWOG Clinical Trial Number
SWOG-8833
Phase ll Investigation of Chlorambucil and Fludarabine Monophosphate in Relapsed or Refractory Chronic Lymphocytic Leukemia
Activated
05-15-1989
Closed
04-15-1991
Closed
Phase
SWOG Clinical Trial Number
SWOG-8854
Closed
Phase
Accrual
36%
Published
SWOG Clinical Trial Number
SWOG-8812
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8814
Phase lll Comparison of Adjuvant Chemoendocrine Therapy with CAF and Concurrent or Delayed Tamoxifen to Tamoxifen Alone in Postmenopausal Patients with Involved Axillary Lymph Nodes and Positive Receptors (Intergroup)
Research Committee(s)
Breast Cancer
Activated
05-15-1989
Closed
08-01-1995
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8900
A Phase II Pilot of VAD and VAD/Verapamil for Refractory Multiple Myeloma
Activated
05-01-1989
Closed
12-01-1991
Closed
Phase
Accrual
6%
SWOG Clinical Trial Number
SWOG-8822
A Phase II Study of Continuous Infusion Recombinant Interleukin-2 (r-IL-2) in Patients with Malignant Lymphoma
Activated
05-01-1989
Closed
06-15-1991
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8824
A Phase II Study of Continuous Infusion Recombinant Interleukin-2 (rIL-2) in Patients with Advanced Renal Cell Carcinoma
Activated
05-01-1989
Closed
08-15-1991
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8708
Treatment of Hormonally Refractory Stage D Carcinoma of the Prostate with CHIP
Activated
04-01-1989
Closed
09-01-1990
Closed
Phase
Accrual
10%
SWOG Clinical Trial Number
SWOG-8830
A Phase II Study of Continuous Infusion Recombinant Interleukin-2 (rIL-2) in Patients with Ovarian Cancer
Activated
04-01-1989
Closed
11-15-1990